Gene · 7518
Papers3,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36672401 | PubTator, text mining | PubMed |
| Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway. | Blood Cancer J | 2023 | 36670103 | PubTator, text mining | PubMed |
| Nucleic acid drug vectors for diagnosis and treatment of brain diseases. | Signal Transduct Target Ther | 2023 | 36650130 | PubTator, text mining | PubMed |
| Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK. | J Oncol | 2023 | 36644234 | PubTator, text mining | PubMed |
| International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. | Endocr Rev | 2023 | 36635911 | PubTator, text mining | PubMed |
| Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. | J Ovarian Res | 2023 | 36611214 | PubTator, text mining | PubMed |
| Human DNA-dependent protein kinase activation mechanism. | Nat Struct Mol Biol | 2023 | 36604499 | PubTator, text mining | PubMed |
| Pol X DNA polymerases contribute to NHEJ flexibility. | Nat Struct Mol Biol | 2023 | 36587186 | PubTator, text mining | PubMed |
| PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. | Asian J Androl | 2023 | 36537376 | PubTator, text mining | PubMed |
| Polλ promotes microhomology-mediated end-joining. | Nat Struct Mol Biol | 2023 | 36536104 | PubTator, text mining | PubMed |
| Genome stability‑related lncRNA ZFPM2‑AS1 promotes tumor progression via miR‑3065‑5p/XRCC4 in hepatocellular carcinoma. | Int J Oncol | 2023 | 36524359 | PubTator, text mining | PubMed |
| Quantification of protein enrichment at site-specific DNA double-strand breaks by chromatin immunoprecipitation in cultured human cells. | STAR Protoc | 2023 | 36520630 | PubTator, text mining | PubMed |
| Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene. | Oncogene | 2023 | 36443396 | PubTator, text mining | PubMed |
| Double-strand break repair and mis-repair in 3D. | DNA Repair (Amst) | 2023 | 36436496 | PubTator, text mining | PubMed |
| The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. | Oncogene | 2023 | 36434179 | PubTator, text mining | PubMed |
| Androgen Enhances Aflatoxin-induced Genotoxicity and Inflammation to Liver Cancer in Male Hepatitis B Patients. | Cell Mol Gastroenterol Hepatol | 2023 | 36427539 | PubTator, text mining | PubMed |
| Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36406320 | PubTator, text mining | PubMed |
| Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. | J Pathol | 2023 | 36373784 | PubTator, text mining | PubMed |
| APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage. | FEBS J | 2023 | 36325681 | PubTator, text mining | PubMed |
| Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2023 | 36307901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7518/papers?page=16